Malaria News and Research

Latest Malaria News and Research

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

"No one denies" that the oral polio vaccine "has considerable merits. It's cheap to make. It's easy to administer; you don't need a trained nurse with a clean syringe [like the inactive vaccine needs], just a volunteer with a dropper. And it gives excellent immunity. ... But there are problems with the method," Wendy Orent, author of the book Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease, writes in a Los Angeles Times opinion piece.

10 Feb 2011

International AIDS Society urges donors and governments to continue funding

Following the publication of several media reports which seriously distort the extent of fraud discovered in grants financed by the Global Fund to Fight AIDS, TB and Malaria, the International AIDS Society (IAS) urges all donors and governments to continue their funding.

9 Feb 2011

Gates Foundation awards USF $5.45M for malaria research

The University of South Florida received $5.45 million in grants from the Bill & Melinda Gates Foundation. The first grant is to create advanced devices that mimic the human liver to better study the life cycle of the malaria parasite - particularly the elusive liver stage where the disease may be most vulnerable to attack.

9 Feb 2011

New study shows economic burden of dengue in Western Hemisphere is $2.1 billion per year

Dengue illness, the most common mosquito-borne viral disease in the world, has expanded from its Southeast Asian origins and is resurgent in countries such as Argentina, Chile and the continental United States.

8 Feb 2011

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.

7 Feb 2011

Global Fund announces measures to increase fraud detection, prevention

The Global Fund To Fight AIDS, Tuberculosis and Malaria on Thursday announced "it is to launch a wide-ranging review of its procedures following concern over mismanagement of funds by countries receiving its money," the Financial Times reports. The U.N.-backed organization "which channels $3bn a year in donor funds to developing countries, will restructure its auditing procedures and appoint outside officials to review its systems," according to the news service.

5 Feb 2011

Newly identified mosquito subspecies highly susceptible to malaria parasite, prefers outdoors

"Researchers have discovered a previously unknown subspecies of mosquito in West Africa that is highly susceptible to the malaria parasite and whose existence may stymie efforts to eradicate the deadly disease," the Los Angeles Times reports (Khan, 2/4).

5 Feb 2011

Recent releases in Global Health

"Africa should be one of the leading regions in shaping global food security policies and feeding the future instead of others shaping it for Africa. Developing practical, integrative and more small-scale solutions for agricultural inputs and outputs, farming, and for managing both land and water resources, will help Africa provide for future generations on the Continent and elsewhere," Robin Renee Sanders, the U.S. ambassador to Nigeria, writes in a Huffington Post blog post.

5 Feb 2011

Opinions: Global Fund; Accountability for Haiti Aid

Washington Post columnist Michael Gerson writes of the "breathless Associated Press story" about the uncovering of some corruption in grants given by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the subsequent reaction: "When scandals fit preexisting ideological narratives, they assume a life of their own. This particular narrative - the story of useless, wasted aid - is durable. It is also misleading and might be deadly."

4 Feb 2011

American Cancer Society report released on World Cancer Day

A new American Cancer Society report says cancers associated with lifestyles and behaviors related to economic development, including lung, breast, and colorectal cancers, will continue to rise in developing countries if preventive measures are not widely applied. The finding comes from the second edition of Global Cancer Facts & Figures and its academic publication, Global Cancer Statistics, published in CA: A Cancer Journal for Clinicians.

4 Feb 2011

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Cepheid and FIND today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus viral load.

3 Feb 2011

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Three studies published on Tuesday in PLoS Medicine show that "intermittent use of preventive antimalarial drugs can be beneficial in curbing the spread of the disease in children," Agence France-Presse reports (2/1).

3 Feb 2011

Malaria transmission to decline in Burundi because of global warming

Malaria transmission will not increase because of global warming in the African nation of Burundi according to a statistical analysis by researchers in Austria and Burundi. Writing in the International Journal of Global Warming, the team explains that rising temperatures will lead to lower humidity and rainfall which will shorten the lifespan of mosquitoes carrying malaria.

3 Feb 2011

Malarial drugs may help treat specific form of frontotemporal dementia

Frontotemporal dementia is caused by a breakdown of nerve cells in the frontal and temporal region of the brain, which leads to, among other symptoms, a change in personality and behavior. The cause of some forms of frontotemporal dementia is a genetically determined reduction of a hormone-like growth factor, progranulin.

3 Feb 2011

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of Inovio's SynCon DNA vaccine for prostate cancer targeting two antigens.

2 Feb 2011

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "urged developed nations to help him wipe out polio 'once and for all' at an event to release his third annual letter [.pdf] Monday," Agence France-Presse reports.

2 Feb 2011

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

On the final day of the two-day African Union Summit taking place in Addis Ababa, Ethiopia, U.N. Secretary-General Ban Ki-moon on Monday called for greater efforts to reduce sexual violence, particularly during armed conflicts, Ezega.com reports.

2 Feb 2011

Bill Gates argues the case for polio eradication and expanded childhood immunization

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the case for polio eradication and expanded childhood immunization in his third annual letter released today. The letter, a personal account of his priorities, also calls on governments to invest in foreign aid, even in the face of a tough economic climate.

1 Feb 2011

U.K., Gates Foundation announce extra funding for global polio eradication as WEF wraps up

U.K. Prime Minister David Cameron and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, on Friday at the World Economic Forum (WEF) in Davos, Switzerland, announced "extra financing for polio eradication, easing a shortfall in funding that hinders a global effort to stop the crippling virus," Bloomberg reports.

1 Feb 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

Malaria News and Research

Latest Malaria News and Research

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

International AIDS Society urges donors and governments to continue funding

Gates Foundation awards USF $5.45M for malaria research

New study shows economic burden of dengue in Western Hemisphere is $2.1 billion per year

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Global Fund announces measures to increase fraud detection, prevention

Newly identified mosquito subspecies highly susceptible to malaria parasite, prefers outdoors

Recent releases in Global Health

Opinions: Global Fund; Accountability for Haiti Aid

American Cancer Society report released on World Cancer Day

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Malaria transmission to decline in Burundi because of global warming

Malarial drugs may help treat specific form of frontotemporal dementia

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

At AU Summit, U.N. Secretary-General calls for more efforts to empower women, stop sexual violence

Bill Gates argues the case for polio eradication and expanded childhood immunization

U.K., Gates Foundation announce extra funding for global polio eradication as WEF wraps up

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Malaria News and Research

Latest Malaria News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in